Home › Heart Valve Diseases › California › Los Angeles
Heart Valve Diseases clinical trials in Los Angeles, CA
3 studies for Heart Valve Diseases are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- PIH Health Good Samaritan Hospital, Los Angeles
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Keck Hospital of the University of Southern California, USC, Los Angeles
- and 1 more
Abbott Structural Heart Device Registry
RecruitingObservational study
- USC University Hospital, Los Angeles
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- Keck School of Medicine of USC, Los Angeles
- UCLA Medical Center, Los Angeles
About Heart Valve Diseases
Heart valve disease happens when one or more of your heart valves do not open or close correctly. This can affect your blood flow and strain your heart.
More about Heart Valve Diseases on MedlinePlus
Heart Valve Diseases trials in other cities
- New York City, NY11 studies
- Cleveland, OH10 studies
- Chicago, IL5 studies
- Phoenix, AZ5 studies
- Cincinnati, OH5 studies
- Minneapolis, MN5 studies
- Atlanta, GA4 studies
- Pittsburgh, PA4 studies
- Houston, TX4 studies
- Philadelphia, PA4 studies
- Boston, MA4 studies
- Thousand Oaks, CA3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.